by Kirstie Ganobsik Hepatitis C is a viral infection of the liver no one wants to catch, so knowing how that can happen can be critical. The American Liver Foundation estimates that it affects about 2.7 million people in the United States today. To help you protect yourself against this virus, liver experts describe how you get hepatitis C,...
by Mandi Harenberg Hepatitis C is often missed in the early stages of infection, so you need to know what symptoms might spell trouble. According to the U.S. Centers for Disease Control and Prevention, hepatitis C infections, which attack the liver, are increasing at a faster rate than a decade ago. While there’s no need for...
by Ann Schreiber Hepatitis C is a serious viral infection that can scar your liver, cause your liver to fail and raise your risk for liver cancer, but there are a multitude of medications that can treat it. According to the U.S. Department of Health and Human Services, an estimated 2.4 million Americans live with hepatitis...
by Ariana Baldassano, Rush University Medical Center Credit: Pixabay/CC0 Public Domain Why does the White House want to put $11.3 billion toward eliminating hepatitis C? Because as many as 75% of people who have it don’t know it. Nearly a decade after the FDA approved the first antiviral pill to cure hepatitis C, people most likely won’t know...
by Franny White, Oregon Health & Science University Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University. A health care team at Oregon Health & Science University is trying a different approach to caring for patients who have,...
by American Heart Association Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University. As people with HIV age, their risk of heart attack increases far more if they also have untreated hepatitis C virus, even if their HIV...
by The City University of New York Graphical abstract. Credit: JAMA Internal Medicine (2022). DOI: 10.1001/jamainternmed.2022.0170 A study by CUNY SPH researchers, in close partnership with colleagues from Weill Cornell Medicine and NYU School of Medicine, suggests that treating people who inject drugs for hepatitis C infection using the accessible care model, which is characterized by low-threshold,...
UNIVERSITY OF PENNSYLVANIA SCHOOL OF MEDICINE PHILADELPHIA— Without requiring even one extra mouse click, a randomized clinical trial at the Perelman School of Medicine at the University of Pennsylvania doubled the rate of hepatitis C screenings among the patients for whom they’re recommended. The study simply made the screening a default order for patients who met...
by Ross Barker, University of Glasgow Lateral flow detection of HCV LAMP assay. a The mechanism of the lateral flow strip15. Two primers, FLP and BLP, are pre-labeled with Biotin and FITC, respectively. The amplicon resulting from the LAMP reaction, contains both labeled primers as double-stranded DNA represented schematically by two gray lines. It is added onto the sample pad...
IMAGE: CUMULATIVE INCIDENCE OF TUMOR PROGRESSION (A) AND LIVER-RELATED MORTALITY (B) BY KAPLAN-MEIER ANALYSIS. TUMOR PROGRESSION WAS DEFINED AS WHEN HCC PROGRESSES TO MULTIPLE NODULES IN THE LIVER, PORTAL INVASION OR METASTASIZES TO OTHER PARTS OF THE BODY, BRINGING THE DISEASE FROM EARLY- TO ADVANCED-STAGE HCC, ACCORDING TO THE BARCELONA CLINIC LIVER CANCER STAGING SYSTEM....
